Search Results - "Seghezzi, S"

Sense of agency disturbances in movement disorders: A comprehensive review by Seghezzi, S., Convertino, L., Zapparoli, L.

“…•Abnormal agency experiences characterize different movement disorders.•Agency disturbances are associated with SMA structural and functional…”
Get full text

How the effects of actions become our own by Zapparoli, L, Seghezzi, S, Zirone, E, Guidali, G, Tettamanti, M, Banfi, G, Bolognini, N, Paulesu, E

“…Every day, we do things that cause effects in the outside world with little doubt about who caused what. To some, this sense of agency derives from a post hoc…”
Get full text

Bone quality in beta-thalassemia intermedia: relationships with bone quantity and endocrine and hematologic variables by Baldini, Marina, Marcon, A., Ulivieri, F. M., Seghezzi, S., Cassin, R., Messina, C., Cappellini, M. D., Graziadei, G.

“…We report the first evaluation of bone quality in 70 thalassemia intermedia (TI) patients (37 males, 33 females, age 41 ± 12 years). Thirty-three patients…”
Get full text

Spine Bone Texture Assessed by Trabecular Bone Score (TBS) to Evaluate Bone Health in Thalassemia Major by Baldini, M., Ulivieri, F. M., Forti, S., Serafino, S., Seghezzi, S., Marcon, A., Giarda, F., Messina, C., Cassinerio, E., Aubry-Rozier, B., Hans, D., Cappellini, M. D.

“…Due to the increasing survival of thalassemic patients, osteopathy is a mounting clinical problem. Low bone mass alone cannot account for the high fracture…”
Get full text

(131)I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy by Castellani, M R, Seghezzi, S, Chiesa, C, Aliberti, G L, Maccauro, M, Seregni, E, Orunesu, E, Luksch, R, Bombardieri, E

“…Since the second half of the 1980s, (131)I-MIBG has been widely used for treatment of patients with malignant pheochromocytoma. In 1991, at the International…”
Get full text

Stratifying Risk Factors for Multidrug-Resistant Pathogens in Hospitalized Patients Coming From the Community With Pneumonia by Aliberti, Stefano, Di Pasquale, Marta, Zanaboni, Anna Maria, Cosentini, Roberto, Brambilla, Anna Maria, Seghezzi, Sonia, Tarsia, Paolo, Mantera, Marco, Blasi, Francesco

“…Background. Not all risk factors for acquiring multidrug-resistant (MDR) organisms are equivalent in predicting pneumonia caused by resistant pathogens in the…”
Get full text

sup 131^I-MIBG treatment of pheochromocytoma: low versus intermediate activity regimens of therapy by Castellani, M R, Seghezzi, S, Chiesa, C, Aliberti, G L, Maccauro, M, Seregni, E, Orunesu, E, Luksch, R, Bombardieri, E

“…Since the second half of the 1980s, ^sup 131^I-MIBG has been widely used for treatment of patients with malignant pheochromocytoma. In 1991, at the…”
Get full text